Showing 1 - 12 results of 12 for search 'pharmaceutical policy', query time: 0.08s Refine Results
  1. 1

    The Impact of Recent Generic Drug Price Policies on Pharmaceutical Innovation: A Theoretical Rationale and Proposal of a Method Supporting Innovation in Areas of Unmet Medical Need by Pierre-Alexandre Dionne, Farzad Ali, Mendel Grobler

    Published 2016-10-01
    “…This paper highlights the impact of generic drug price policies on pharmaceutical innovation in the context of fixed ICER thresholds and proposes a new consideration for the cost-effectiveness analysis (CEA). …”
    Get full text
    Article
  2. 2

    Estimating Potential for Drug Budget Reallocation Following Expiration of Exclusivity of Pharmaceutical Products by Samira Toghanian, John Moshtaghi-Svensson, Maria Papageorgiou, Kristin Kittelsen, Christiaan Dolk, Markus Hultstrand, Stina Salomonsson

    Published 2022-02-01
    “…**Discussion:** These analyses showed that LOE for pharmaceutical products between 2020 and 2022 can result in significant increase in budget availability. …”
    Get full text
    Article
  3. 3

    The role of Pharmaceutical Marketing in Prescribing Decisions in a Developing Country: A Comprehensive Study Exploiting Theory of Planned Behaviour by Mahmoud Al-Areefi, Mohamed Izham Mohamed Ibrahim, Abubakr Abdelraouf Alfadl

    Published 2024-11-01
    “…Conclusion: This research clarified the role played by pharmaceutical companies to influence prescribing decisions of physicians. …”
    Get full text
    Article
  4. 4

    ASSESSMENT OF THE REGION'S INVESTMENT ENVIRONMENT AND POLICY INSTRUMENTS FOR THE IMPLEMENTATION OF ITS INVESTMENT POTENTIAL IN WARTIME by Ruslan Boiko, Roman Martsenyuk, Arsen Protsykevych

    Published 2024-12-01
    “…It is substantiated that effective instruments of regional investment policy in the context of critical instability are: military risk insurance and diversification; use of concession agreements; private and public investments in the defence industry and critical infrastructure industries/sectors (energy, transport and logistics, medicine and pharmaceuticals, natural resources); support for innovative and technological startups in the areas of security, the real economy and infrastructure; stimulation of investments in human resources; support for investments in business projects of demobilised persons, war veterans and other combatants; encouragement of investments in the development of export potential to maintain the country's financial security.…”
    Get full text
    Article
  5. 5
  6. 6

    Impacts of National Reimbursement Drug Price Negotiation on drug accessibility, utilization, and cost in China: a systematic review by Zheng Zhu, Jiawei Zhang, Zhihu Xu, Quan Wang, Yu Qi, Li Yang

    Published 2025-02-01
    “…The published studies indicated the implementation of the NRDPN policy decreased drug prices, ranging from 24 to 72%, which increased the affordability of success-negotiated drugs (refer to those medications that have undergone a successful price negotiation process between pharmaceutical companies and healthcare authorities) and decreased out-of-pocket expenditures. …”
    Get full text
    Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12